Price $3.01 |
Market Cap
14.6M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
1.84
|
P/S
57.33
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
-4.9K
|
FCF
-0.8
|
|
Op. Margin
-
|
Net Margin
-
|
ROE
-72.20%
|
ROI
-93.50%
|
|
ROA
-72.50%
|
EPS Growth
-45.20%
|
Current Ratio
35.0
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Avalo Therapeutics Inc (AVTX) | $3.89 | - | - | 47.6M | Strong Buy |
| Anika Therapeutics Inc (ANIK) | $32.10 | - | - | 427.8M | Strong Buy |
| Ligand Pharmaceuticals Inc (LGND) | $71.45 | - | - | 1.14B | Strong Buy |
| Community Health Systems Inc (CYH) | $5.33 | - | - | 576.6M | Strong Buy |
| Emmaus Life Sciences Inc (EMMA) | $0.38 | - | - | 14.9M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
